Thomas Smeenk

Thomas Smeenk

Founder chez HEMOSTEMIX INC.

Fortune : 84 628 $ au 31/03/2024

Health Technology
Technology Services
Non-Energy Minerals

Profil

Thomas A.
Smeenk
is the founder of Hemostemix, Inc. (founded in 2006) and currently holds the title of President, Chief Executive Officer & Director.
Mr. Smeenk is also the founder of TheraVitae, Inc...
Mr. Smeenk's former job positions include President & Chief Executive Officer at e-Manufacturing Networks, Inc., President & Chief Executive Officer at IBI Corp., President & Chief Executive Officer at Stroud Resources Ltd., President & Chief Executive Officer at Broadway Gold Mining Ltd., President & Chief Executive Officer at Tyranex Gold, Inc., Director-Business Development at BMG Group, Inc., and Vice President-Business Development at Memex, Inc. (Canada).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/05/2024 1 800 593 ( 2,07% ) 84 628 $ 31/03/2024

Postes actifs de Thomas Smeenk

SociétésPosteDébut
HEMOSTEMIX INC. Founder 01/01/2006
Tous les postes actifs de Thomas Smeenk

Anciens postes connus de Thomas Smeenk

SociétésPosteFin
STROUD RESOURCES LTD. Chief Executive Officer 22/07/2019
BROADWAY GOLD MINING LTD. Chief Executive Officer 01/04/2019
Corporate Officer/Principal 01/11/2017
Founder 15/02/2017
MEMEX INC. Corporate Officer/Principal 16/12/2014
Voir l'expérience en détail de Thomas Smeenk

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas Smeenk

Relations

41

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
STROUD RESOURCES LTD.

Non-Energy Minerals

HEMOSTEMIX INC.

Health Technology

MEMEX INC.

Technology Services

Entreprise privées6
e-Manufacturing Networks, Inc.

Technology Services

Non-Energy Minerals

Health Technology

Health Technology

Finance

Tyranex Gold, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas Smeenk